Prescription Required
Formulation: Delayed Release Tablet
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Delayed Release Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Myfortic is a prescription medication that contains mycophenolic acid as its active ingredient.
It is an immunosuppressant used mainly in people who have received a kidney transplant. Its purpose is to reduce the immune system’s ability to attack the transplanted kidney.
Myfortic is used to help prevent rejection of a transplanted kidney.
After a kidney transplant, the immune system may identify the new kidney as foreign tissue and attempt to attack it. This immune response can damage the transplanted organ and interfere with how well it functions.
Myfortic helps suppress this response so the transplanted kidney has a better chance of continuing to function properly.
Organ rejection happens when immune cells recognize the transplanted kidney as something that does not naturally belong in the body.
Myfortic reduces the activity and growth of specific immune cells involved in this process.
By weakening this part of the immune response, Myfortic helps reduce the likelihood that the body will attack and damage the transplanted kidney.
Myfortic belongs to a class of medications called immunosuppressants.
Mycophenolic acid blocks an enzyme called inosine monophosphate dehydrogenase, or IMPDH. This enzyme is important for the production of guanosine nucleotides, substances that certain immune cells need in order to multiply.
T lymphocytes and B lymphocytes are especially dependent on this pathway.
By limiting their ability to multiply, Myfortic reduces the immune activity that can lead to transplant rejection.
T lymphocytes and B lymphocytes are types of white blood cells that play important roles in the immune system.
T cells help recognize and attack cells that the body considers foreign, while B cells help produce antibodies.
These immune responses are normally useful for protecting the body from infections. After an organ transplant, however, the same response can target the transplanted kidney.
Myfortic helps reduce the activity of these cells to protect the transplanted organ.
Myfortic is usually prescribed together with other immunosuppressive medications rather than used alone.
Different immunosuppressants act on different parts of the immune system. Combining them can provide more effective protection against transplant rejection.
Depending on the treatment plan, Myfortic may be used with medications such as corticosteroids, tacrolimus, or cyclosporine.
The exact combination depends on the patient’s transplant history, kidney function, risk of rejection, and tolerance of the medications.
Myfortic contains mycophenolic acid in an enteric-coated, delayed-release form.
Mycophenolate mofetil is a different formulation that is converted into mycophenolic acid after it is taken.
Although both ultimately provide mycophenolic acid, the products are absorbed differently and are not interchangeable on a milligram-for-milligram basis.
Do not switch between Myfortic and another mycophenolate product unless your transplant healthcare provider specifically directs you to do so.
Myfortic is often used as part of long-term immunosuppressive therapy after a kidney transplant.
The length of treatment depends on your transplant status, risk of rejection, response to therapy, and overall health.
Some patients may need immunosuppressive treatment for as long as the transplanted kidney remains functioning.
No. A well-functioning transplanted kidney does not necessarily mean immunosuppression is no longer needed.
The immune system can still recognize the transplanted organ as foreign, even years after surgery.
Stopping Myfortic suddenly or skipping doses can increase the risk of rejection.
Do not stop taking Myfortic or change the dose unless your transplant healthcare provider tells you to do so.
No. Myfortic does not cure the kidney disease that originally led to transplantation.
Its role is to help protect the transplanted kidney by reducing the immune response that can cause rejection.
Continued transplant care, laboratory testing, and other medications may still be necessary.
Myfortic suppresses the immune system, so careful medical monitoring is necessary.
Your healthcare provider may regularly check:
These tests help your transplant team determine whether treatment remains effective and safe.
Myfortic works best when taken consistently according to the prescribed schedule.
Missing doses can reduce the level of immunosuppression and may increase the risk of rejection.
Because transplant medications often need to be coordinated carefully, follow your healthcare provider’s dosing instructions closely and contact your transplant team if you miss doses or have difficulty taking the medication as prescribed.
Myfortic is taken by mouth, usually twice daily.
Take it exactly as prescribed by your transplant healthcare provider and try to take each dose at the same times every day.
Consistency is especially important with transplant medications because missed or irregular doses can increase the risk of organ rejection.
Myfortic is usually taken on an empty stomach.
Take each dose:
Try to take it the same way each day in relation to meals.
Swallow Myfortic tablets whole with water.
Do not crush, chew, or split the tablets because they have a delayed-release coating designed to control where the medication is released.
If you have trouble swallowing the tablets, contact your healthcare provider rather than altering them.
For adults who have received a kidney transplant, the usual dose is:
720 mg taken twice daily
The doses are generally spaced about 12 hours apart.
Your transplant team may adjust the dose based on your response, side effects, blood test results, and other medications you take.
For children 5 years of age and older who have received a kidney transplant, the dose is usually based on body surface area, which is calculated using height and weight.
The dose is given twice daily and should not exceed 720 mg per dose.
Pediatric dosing should always be calculated and monitored by the transplant healthcare team.
Do not increase, decrease, or stop Myfortic without instructions from your transplant healthcare provider.
Even if you feel well and your transplanted kidney is functioning normally, stopping or reducing immunosuppressive treatment can increase the risk of rejection.
If you miss a dose of Myfortic, contact your transplant healthcare provider or pharmacist for instructions, especially if you are unsure how close you are to the next scheduled dose.
In general, do not take two doses at the same time or take extra tablets to make up for a missed dose.
Because Myfortic is used to prevent organ rejection, repeated missed doses should be discussed with your transplant team promptly.
Myfortic tablets should be handled carefully.
Avoid crushing or breaking the tablets, as this can expose you to mycophenolic acid.
If powder or material from a damaged tablet comes into contact with your skin, wash the area thoroughly with soap and water.
If it gets into your eyes, rinse them with plain water.
Mycophenolic acid can cause serious harm to an unborn baby.
People who are pregnant or may become pregnant should avoid handling crushed or broken Myfortic tablets or breathing in powder from damaged tablets.
Follow any additional handling precautions provided by your pharmacist or transplant team.
Take Myfortic consistently at the prescribed times every day.
Do not skip doses simply because you feel well. Myfortic works by continuously suppressing the immune response that could attack the transplanted kidney.
Your transplant healthcare provider may regularly monitor:
These checks help determine whether your current Myfortic dose remains safe and effective.
Myfortic (Mycophenolic Acid) is available in the following forms and strengths:
Myfortic suppresses the immune system and can increase the risk of serious infections, certain cancers, blood cell problems, and pregnancy-related harm.
It should be prescribed and monitored by healthcare professionals experienced in transplant medicine and immunosuppressive therapy.
Myfortic can weaken the immune system and make it harder to fight infections.
Seek prompt medical attention if you develop symptoms such as fever, chills, persistent cough, shortness of breath, painful urination, or unusual weakness.
Serious bacterial, viral, fungal, and opportunistic infections can occur during treatment.
Long-term use of immunosuppressive medications such as Myfortic can increase the risk of lymphoma and skin cancer.
Contact your healthcare provider if you notice unusual lumps, unexplained weight loss, persistent fever, or other concerning symptoms.
Limit unnecessary sun exposure and use appropriate sun protection.
Myfortic can cause bone marrow suppression and may lower red blood cells, white blood cells, or platelets.
This may lead to anemia, leukopenia, increased infection risk, or abnormal bleeding.
Contact your healthcare provider if you develop unusual bruising, persistent fatigue, frequent infections, or bleeding that is difficult to stop.
Myfortic can rarely cause serious gastrointestinal problems, including ulceration or bleeding.
Seek medical attention if you develop severe abdominal pain, vomit blood, or notice black, tarry stools.
Tell your healthcare provider if you have a history of peptic ulcers, gastrointestinal bleeding, or other significant digestive problems.
Myfortic may cause nausea, vomiting, diarrhea, and abdominal discomfort, and existing gastrointestinal conditions may require closer monitoring.
Myfortic can cause miscarriage and serious birth defects.
It should generally be avoided during pregnancy unless no suitable alternative is available and the benefits clearly outweigh the risks.
Patients who can become pregnant may need pregnancy testing and effective contraception before, during, and for a recommended period after treatment.
Talk to your healthcare provider before breastfeeding while taking Myfortic.
Because mycophenolic acid may pass into breast milk and could harm a nursing infant, your provider will help determine whether breastfeeding or treatment should be continued.
Myfortic can interact with other medications and may change how well they work or increase the risk of side effects.
Tell your healthcare provider and pharmacist about all prescription medications, over-the-counter products, vitamins, and supplements you take before starting treatment.
Do not start or stop another medication without checking for possible interactions.
Kidney transplant patients require regular monitoring of kidney function.
Changes in kidney function may be related to the transplant, other medications, dehydration, infection, or other causes.
Contact your transplant team if you notice reduced urination, swelling, sudden weight gain, or other significant changes.
Because Myfortic can increase the risk of skin cancer, reduce unnecessary exposure to sunlight and ultraviolet light.
Use protective clothing and broad-spectrum sunscreen when outdoors, and report new or changing skin lesions to your healthcare provider.
Your transplant healthcare team may regularly monitor:
Keep all scheduled appointments and blood tests while taking Myfortic.
Report unusual bruising, persistent fever, severe diarrhea, abdominal pain, signs of infection, or other new or worsening symptoms promptly.
No. Do not stop taking Myfortic without first speaking with your transplant healthcare provider. Myfortic helps suppress the immune response that can attack a transplanted kidney. Even if you feel well and your kidney is functioning properly, stopping treatment can increase the risk of transplant rejection. Always follow your prescribed dosing schedule unless your healthcare provider tells you to make a change.
Myfortic can cause serious harm to an unborn baby and is generally avoided during pregnancy. If you are pregnant, planning to become pregnant, or think you may be pregnant, contact your healthcare provider promptly. Patients who can become pregnant may need pregnancy testing and effective contraception before, during, and for a recommended period after treatment. Breastfeeding is also generally not recommended while taking Myfortic because mycophenolic acid may pose a risk to a nursing infant. Discuss feeding options with your healthcare provider.
Store Myfortic at room temperature in its original container. Keep it away from excessive heat, moisture, and direct light. Store the medication in a secure place out of the reach of children and pets, and follow any additional storage instructions on the pharmacy label.
Yes. Myfortic can interact with certain medications and supplements. This includes some antacids containing magnesium or aluminum, bile acid-binding medications such as cholestyramine, and other drugs that may affect how mycophenolic acid is absorbed or eliminated. Tell your healthcare provider and pharmacist about all prescription medications, over-the-counter drugs, vitamins, supplements, and herbal products you use. Do not start, stop, or change another medication without first checking whether it can interact with Myfortic.
| Generic name: | Mycophenolic Acid, Mycophenolic acid |
|---|---|
| Formulation: | Delayed Release Tablet, Tablet |
| Strength(s): | 180mg, 360mg |
| Quantities Available: | 100, 120 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Myfortic (mycophenolic acid) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Myfortic is commonly prescribed in dosages of 180 mg or 360 mg tablets, taken twice daily. For a 90-day supply, you would order 180 tablets (90 days x 2 tablets per day).
Yes, we sell mycophenolic acid on our website. You can enjoy low prices when you order through us. To purchase mycophenolic acid, you will need a valid prescription from your healthcare provider, as we require this to dispense the medication safely and appropriately. You can mail, fax, or upload your prescription through your online account.
Yes, we ship Myfortic (mycophenolic acid) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Myfortic (Mycophenolic acid). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Myfortic (Mycophenolic acid).
REVIEWS